Quantum BioPharma Balance Sheet Health
Financial Health criteria checks 4/6
Quantum BioPharma has a total shareholder equity of $15.3M and total debt of $300.5K, which brings its debt-to-equity ratio to 2%. Its total assets and total liabilities are $19.0M and $3.7M respectively.
Key information
2.0%
Debt to equity ratio
US$300.55k
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.61m |
| Equity | US$15.35m |
| Total liabilities | US$3.68m |
| Total assets | US$19.03m |
Recent financial health updates
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate
Apr 13
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate
Dec 17Recent updates
Financial Position Analysis
Short Term Liabilities: QNTM's short term assets ($13.8M) exceed its short term liabilities ($3.7M).
Long Term Liabilities: QNTM has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: QNTM has more cash than its total debt.
Reducing Debt: QNTM's debt to equity ratio has reduced from 3.2% to 2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: QNTM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: QNTM has less than a year of cash runway if free cash flow continues to grow at historical rates of 3.1% each year.